Trials / Unknown
UnknownNCT00700323
PS-Omega3 Supplementation to Attention Deficit Hyperactivity Disorder (ADHD) Children
Phase 2b Study of PS-Omega3 Conjugate Supplementation to ADHD Diagnosed Children
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- Sponsor
- Tel-Aviv Sourasky Medical Center · Other Government
- Sex
- All
- Age
- 8 Years – 13 Years
- Healthy volunteers
- Not accepted
Summary
To assess the effect of phosphatidylserine-omega-3 consumption on the immune system parameters in children suffering from attention and concentration deficits.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | PS-Omega3 conjugate supplementation | |
| DIETARY_SUPPLEMENT | placebo |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2008-06-18
- Last updated
- 2008-06-18
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00700323. Inclusion in this directory is not an endorsement.